Lupus Clinical Trial
Official title:
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Lupus
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Lupus
Studies have shown that stem cell treatment is safe and efficacious for the treatment of Lupus. This patient funded trial aims to study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells (UC-MSCs) for the treatment of Lupus. Patients with Lupus will receive a single intravenous infusion of UC-MSCs. The total dose will be 100 million cells. Patients will be evaluated within one month pre treatment and at 1, 6, 12, 24, 36, and 48 months post treatment for safety and efficacy. For patients with more severe disease an autologous T-Cell vaccine will be utilized created from the patient's own cells obtained by apheresis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013995 -
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
|
Phase 1 | |
| Recruiting |
NCT03952624 -
Patient-Centered Assessment of Symptoms and Outcomes
|
||
| Terminated |
NCT01389895 -
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00710021 -
Vitamin D3 in Systemic Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT02265744 -
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT00581763 -
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
|
N/A | |
| Recruiting |
NCT01172002 -
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
|
N/A | |
| Completed |
NCT00299819 -
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
| Completed |
NCT00054938 -
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
|
Phase 2 | |
| Terminated |
NCT03953690 -
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
|
||
| Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
| Enrolling by invitation |
NCT05321108 -
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus
|
N/A | |
| Completed |
NCT00482989 -
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00657189 -
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
|
Phase 2 | |
| Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
| Completed |
NCT03402087 -
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
|
Phase 1 | |
| Completed |
NCT02857452 -
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
|
N/A | |
| Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
| Recruiting |
NCT05922722 -
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
|
||
| Completed |
NCT03093402 -
JBT-101 in Systemic Lupus Erythematosus (SLE)
|
Phase 2 |